Menu

Built from government registry data

Another treatment route
may be closer than it seems

If you or someone close to you is exploring additional treatment options, you can search here for clinical trials worldwide that are currently enrolling. The catalogue is a starting point; final eligibility is always assessed by the study center together with the treating physician.

Registry data refreshed:

Examples — any diagnosis works: Lung cancer Melanoma Glioblastoma Multiple sclerosis

99,169 trials worldwide · updated 2026-08-09

Specialties

CAR-T & cell therapy1,352 trials Hematology3,640 trials Lung cancer3,760 trials GI & liver8,202 trials Breast cancer3,150 trials Gynecologic oncology2,351 trials Urology2,917 trials CNS tumors876 trials Other tumors6,064 trials Autoimmune diseases3,520 trials Cardiology9,008 trials Endocrinology4,154 trials Other areas50,175 trials

Where to start

1. Find matching protocolsSearch by diagnosis, country and recruitment status — in the search above or by specialty. Save the NCT numbers: any doctor can find the full protocol by them, and every card links to the primary record in the government registry. 2. Understand how it all worksWhat a clinical trial is, whether it is safe, what it costs, whether there is a placebo — in plain words in our patient guide. 3. Discuss with your doctor — and with usThe decision to participate is made by the treating physician together with the study center. A Lechu coordinator will help contact the center, prepare documents and arrange the trip, free of charge. We reply within one business day.

Patient stories

Real stories of people Lechu accompanied through treatment in China. Full versions are on our CAR-T site.

Stories describe individual experiences. Treatment outcomes vary, and taking part in a trial does not guarantee a medical result.

Nikita, 17 — Burkitt lymphomaThe tumor stopped responding to standard chemotherapy; in February 2026 the family came to one of the leading cell-therapy centers, and Nikita received his CAR-T infusion. Gulnara, 58 — multiple myelomaChemotherapy, radiation and a bone-marrow transplant brought only temporary relief; CAR-T therapy at a partner clinic followed in spring 2025. Lin, 32 — systemic lupus erythematosusMore than ten years of fighting lupus, a third severe relapse — and remission after CAR-T therapy in 2024.

All stories on cart.hospital →

Who we are

Lechu Group has supported patients since 2012. Our help is free for patients — partner clinics pay our fee. More about us and how we work →